270 related articles for article (PubMed ID: 19339276)
21. Prognostic significance of p27(kip-1) expression in colorectal adenocarcinomas is associated with tumor stage.
Manne U; Jhala NC; Jones J; Weiss HL; Chatla C; Meleth S; Suarez-Cuervo C; Grizzle WE
Clin Cancer Res; 2004 Mar; 10(5):1743-52. PubMed ID: 15014027
[TBL] [Abstract][Full Text] [Related]
22. rs4919510 in hsa-mir-608 is associated with outcome but not risk of colorectal cancer.
Ryan BM; McClary AC; Valeri N; Robinson D; Paone A; Bowman ED; Robles AI; Croce C; Harris CC
PLoS One; 2012; 7(5):e36306. PubMed ID: 22606253
[TBL] [Abstract][Full Text] [Related]
23. Molecular staging of colorectal cancer in African-American and Caucasian patients using phenotypic expression of p53, Bcl-2, MUC-1 AND p27(kip-1).
Grizzle WE; Manne U; Weiss HL; Jhala N; Talley L
Int J Cancer; 2002 Feb; 97(4):403-9. PubMed ID: 11802199
[TBL] [Abstract][Full Text] [Related]
24. Age-associated increase of codon 72 Arginine p53 frequency in gastric cardia and non-cardia adenocarcinoma.
Zhang ZW; Newcomb P; Hollowood A; Feakins R; Moorghen M; Storey A; Farthing MJ; Alderson D; Holly J
Clin Cancer Res; 2003 Jun; 9(6):2151-6. PubMed ID: 12796380
[TBL] [Abstract][Full Text] [Related]
25. Bcl-2 expression is associated with improved prognosis in patients with distal colorectal adenocarcinomas.
Manne U; Weiss HL; Grizzle WE
Int J Cancer; 2000 Sep; 89(5):423-30. PubMed ID: 11008204
[TBL] [Abstract][Full Text] [Related]
26. Association between p53 codon 72 polymorphism and sarcoma risk among Caucasians.
Chang Z; Yu X
Tumour Biol; 2014 May; 35(5):4807-12. PubMed ID: 24449505
[TBL] [Abstract][Full Text] [Related]
27. Adrenergic-pathway gene variants influence beta-blocker-related outcomes after acute coronary syndrome in a race-specific manner.
Cresci S; Dorn GW; Jones PG; Beitelshees AL; Li AY; Lenzini PA; Province MA; Spertus JA; Lanfear DE
J Am Coll Cardiol; 2012 Sep; 60(10):898-907. PubMed ID: 22703928
[TBL] [Abstract][Full Text] [Related]
28. The hypofunctional effect of P335L single nucleotide polymorphism on SSTR5 function.
Zhou G; Gingras MC; Liu SH; Li D; Li Z; Catania RL; Stehling KM; Li M; Paganelli G; Gibbs RA; Demayo FJ; Fisher WE; Brunicardi FC
World J Surg; 2011 Aug; 35(8):1715-24. PubMed ID: 21249361
[TBL] [Abstract][Full Text] [Related]
29. p53 polymorphism and age of onset of hereditary nonpolyposis colorectal cancer in a Caucasian population.
Jones JS; Chi X; Gu X; Lynch PM; Amos CI; Frazier ML
Clin Cancer Res; 2004 Sep; 10(17):5845-9. PubMed ID: 15355915
[TBL] [Abstract][Full Text] [Related]
30. The prognostic value of microRNAs varies with patient race/ethnicity and stage of colorectal cancer.
Bovell LC; Shanmugam C; Putcha BD; Katkoori VR; Zhang B; Bae S; Singh KP; Grizzle WE; Manne U
Clin Cancer Res; 2013 Jul; 19(14):3955-65. PubMed ID: 23719259
[TBL] [Abstract][Full Text] [Related]
31. p53 codon 72 and MDM2 SNP309 polymorphisms and age of colorectal cancer onset in Lynch syndrome.
Sotamaa K; Liyanarachchi S; Mecklin JP; Järvinen H; Aaltonen LA; Peltomäki P; de la Chapelle A
Clin Cancer Res; 2005 Oct; 11(19 Pt 1):6840-4. PubMed ID: 16203772
[TBL] [Abstract][Full Text] [Related]
32. High-grade tumor differentiation is an indicator of poor prognosis in African Americans with colonic adenocarcinomas.
Alexander D; Jhala N; Chatla C; Steinhauer J; Funkhouser E; Coffey CS; Grizzle WE; Manne U
Cancer; 2005 May; 103(10):2163-70. PubMed ID: 15816050
[TBL] [Abstract][Full Text] [Related]
33. Frequency of EGFR and KRAS mutations in lung adenocarcinomas in African Americans.
Reinersman JM; Johnson ML; Riely GJ; Chitale DA; Nicastri AD; Soff GA; Schwartz AG; Sima CS; Ayalew G; Lau C; Zakowski MF; Rusch VW; Ladanyi M; Kris MG
J Thorac Oncol; 2011 Jan; 6(1):28-31. PubMed ID: 21107288
[TBL] [Abstract][Full Text] [Related]
34. The effect of race/ethnicity on histological subtype distribution, stage at presentation and cancer specific survival in urethral cancer.
Wenzel M; Deuker M; Stolzenbach F; Nocera L; Collà Ruvolo C; Tian Z; Shariat SF; Saad F; Briganti A; Kluth LA; Chun FKH; Karakiewicz PI
Urol Oncol; 2021 Jun; 39(6):369.e9-369.e17. PubMed ID: 33309509
[TBL] [Abstract][Full Text] [Related]
35. P53 codon 72 polymorphism and lung cancer risk: evidence from 27,958 subjects.
Zhou C; Chen H; Wang A
Tumour Biol; 2013 Oct; 34(5):2961-9. PubMed ID: 23715779
[TBL] [Abstract][Full Text] [Related]
36. The p53 codon 72 polymorphism and susceptibility to colorectal cancer in Korean patients.
Cao Z; Song JH; Park YK; Maeng EJ; Nam SW; Lee JY; Park WS
Neoplasma; 2009; 56(2):114-8. PubMed ID: 19239324
[TBL] [Abstract][Full Text] [Related]
37. The TP53 codon 72 polymorphism may affect the function of TP53 mutations in breast carcinomas but not in colorectal carcinomas.
Langerød A; Bukholm IR; Bregård A; Lønning PE; Andersen TI; Rognum TO; Meling GI; Lothe RA; Børresen-Dale AL
Cancer Epidemiol Biomarkers Prev; 2002 Dec; 11(12):1684-8. PubMed ID: 12496062
[TBL] [Abstract][Full Text] [Related]
38. Correlation of N-myc downstream-regulated gene 1 expression with clinical outcomes of colorectal cancer patients of different race/ethnicity.
Koshiji M; Kumamoto K; Morimura K; Utsumi Y; Aizawa M; Hoshino M; Ohki S; Takenoshita S; Costa M; Commes T; Piquemal D; Harris CC; Tchou-Wong KM
World J Gastroenterol; 2007 May; 13(20):2803-10. PubMed ID: 17569115
[TBL] [Abstract][Full Text] [Related]
39. P53 codon 72 polymorphism and colorectal cancer: a meta-analysis of epidemiological studies.
Liu Y; Qin H; Zhang Y; Shi T; Liu B; Sun Y; Ma Y
Hepatogastroenterology; 2011; 58(112):1926-9. PubMed ID: 22234063
[TBL] [Abstract][Full Text] [Related]
40. p53 mutation arising in Arg72 allele in the tumorigenesis and development of carcinoma of the urinary tract.
Furihata M; Takeuchi T; Matsumoto M; Kurabayashi A; Ohtsuki Y; Terao N; Kuwahara M; Shuin T
Clin Cancer Res; 2002 May; 8(5):1192-5. PubMed ID: 12006537
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
